LSBio
LSBio
Products
Services
Research Areas
Resources
Contact Us
Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting immunostaining in relation to complex human pathologies.

Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding. Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".

LSBio
2401 Fourth Avenue Suite 900
Seattle WA 98121

Phone: 866-819-4732 (Toll Free North America)
206-374-1102 (International)

Fax: 866-206-6909 (Toll Free North America)
206-577-4565 (International)

How to Buy - Details about how to buy our products.

Orders@LSBio.com - To submit a new order.

Customer.Support@LSBio.com - To submit questions about existing orders, pricing, availability, bulk quotes, proforma invoice requests, or other billing issues.

Technical.Support@LSBio.com - To request technical information requests about an LSBio product or its application.

Sales@LSBio.com - To request information about fee-for-service contract IHC studies, IHC reports, distribution agreements, or general business development.

Worldwide Distributors List - To find your local distributor if you're not within the United States.
Products
Services
Research Areas
Resources
Contact Us
NFKB1 / NF‑Kappa‑B Antibody (phospho‑Ser893) LS‑C117429
NF-Kappa-B antibody LS-C117429 is an unconjugated rabbit polyclonal antibody to human NF-Kappa-B (NFKB1). Validated for IHC, Peptide-ELISA and WB.
Catalog
Size
Price
LS-C117429-50
50 µl
Unavailable
LS-C117429-100
100 µl
Unavailable

Popular NFKB1 / NF-Kappa-B Products

Anti-NFKB1 antibody IHC of human thymus. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody LS-B1483 concentration 10 ug/ml.
Species: Human
Applications: IHC, IHC - Paraffin, Western blot
Anti-NFKB1 antibody IHC of human adrenal. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody LS-B1667 dilution 1:50.
Species: Human, Mouse, Rat
Applications: IHC, IHC - Paraffin, Western blot
Anti-NFKB1 antibody IHC of human tonsil. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody LS-B1668 concentration 15 ug/ml.
Species: Human
Applications: IHC, IHC - Paraffin, Immunofluorescence, Western blot
NFKB1 antibody LS-C112312 Western blot of 1 Cell lysate. Antibody concentration 1 ug/ml.  This image was taken for the unconjugated form of this product. Other forms have not been tested.
Species: Human, Monkey, Mouse, Rat, Dog, Horse, Rabbit
Applications: Western blot
Anti-NF-KappaB p105 antibody IHC of human spleen. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody LS-B8072 dilution 5-10 ug/ml.  This image was taken for the unconjugated form of this product. Other forms have not been tested.
Species: Human, Monkey, Mouse, Rat, Bat, Bovine, Dog, Guinea pig, Horse, Pig, Zebrafish
Applications: IHC, IHC - Paraffin, Western blot

Product Description

NF-Kappa-B antibody LS-C117429 is an unconjugated rabbit polyclonal antibody to human NF-Kappa-B (NFKB1). Validated for IHC, Peptide-ELISA and WB.
About NFKB1 / NF-Kappa-B
NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. P19838 NM_003998 NP_003989.2

NFKB1 Antibody, Ebp- 1 Antibody, EBP-1 Antibody, NF-KappaB p50 Antibody, NFkappaB Antibody, NFKB-p50 Antibody, KBF1 Antibody, NF-kappa-B Antibody, NF-kappaB Antibody, NF-kB1 Antibody, NFKB-p105 Antibody, p105 Antibody, p50 Antibody, DNA binding factor KBF1 Antibody, DNA-binding factor KBF1 Antibody, NF-kappabeta Antibody


Specifications

Target
Human NFKB1 / NF-Kappa-B
Host
Rabbit
Reactivity
Human (tested or 100% immunogen sequence identity)
Clonality
IgG Polyclonal
Conjugations
Unconjugated
Purification
Immunoaffinity purified
Modifications
Unmodified
Applications
  • IHC
  • IHC - Paraffin (1:50 - 1:100)
  • Western blot (1:500 - 1:1000)
  • Peptide Enzyme-Linked Immunosorbent Assay (1:20000)
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
Immunogen
Synthetic peptide from human NF-kappaB p105/p50 around the phosphorylation site of Ser893.
Epitope
pSer893
Specificity
NF-kappaB p105/p50 (Phospho-Ser893) Antibody detects endogenous levels of NF-kappaB p105/p50 only when phosphorylated at serine893.
Presentation
PBS (without Mg2+, Ca2+), pH 7.4, 150 mM sodium chloride, 0.02% sodium azide, 50% glycerol
Storage
Store at -20°C for up to 1 year.
Restrictions
For research use only.
Guarantee
This antibody carries the LSBio 100% Guarantee.

Publications (0)


Customer Reviews (0)


Images


Immunohistochemistry

IHC of paraffin-embedded human breast carcinoma, using NF-kappaB p105/p50 (Phospho-Ser893) Antibody. The picture on the right is treated with the synthesized peptide.
IHC of paraffin-embedded human breast carcinoma, using NF-kappaB p105/p50 (Phospho-Ser893) Antibody. The picture on the right is treated with the synthesized peptide.

Western blot

Western blot of extracts from HeLa cells, using NF-kappaB p105/p50 (Phospho-Ser893) Antibody. The lane on the left is treated with the synthesized peptide.
Western blot of extracts from HeLa cells, using NF-kappaB p105/p50 (Phospho-Ser893) Antibody. The lane on the left is treated with the synthesized peptide.

Immunohistochemistry

IHC of paraffin-embedded human breast carcinoma, using NF-kappaB p105/p50 (Phospho-Ser893) Antibody. The picture on the right is treated with the synthesized peptide.
IHC of paraffin-embedded human breast carcinoma, using NF-kappaB p105/p50 (Phospho-Ser893) Antibody. The picture on the right is treated with the synthesized peptide.

Western blot

Western blot of extracts from HeLa cells, using NF-kappaB p105/p50 (Phospho-Ser893) Antibody. The lane on the left is treated with the synthesized peptide.
Western blot of extracts from HeLa cells, using NF-kappaB p105/p50 (Phospho-Ser893) Antibody. The lane on the left is treated with the synthesized peptide.

Immunohistochemistry

IHC of paraffin-embedded human breast carcinoma, using NF-kappaB p105/p50 (Phospho-Ser893) Antibody. The picture on the right is treated with the synthesized peptide.
IHC of paraffin-embedded human breast carcinoma, using NF-kappaB p105/p50 (Phospho-Ser893) Antibody. The picture on the right is treated with the synthesized peptide.

Western blot

Western blot of extracts from HeLa cells, using NF-kappaB p105/p50 (Phospho-Ser893) Antibody. The lane on the left is treated with the synthesized peptide.
Western blot of extracts from HeLa cells, using NF-kappaB p105/p50 (Phospho-Ser893) Antibody. The lane on the left is treated with the synthesized peptide.

Immunohistochemistry

IHC of paraffin-embedded human breast carcinoma, using NF-kappaB p105/p50 (Phospho-Ser893) Antibody. The picture on the right is treated with the synthesized peptide.
IHC of paraffin-embedded human breast carcinoma, using NF-kappaB p105/p50 (Phospho-Ser893) Antibody. The picture on the right is treated with the synthesized peptide.

Western blot

Western blot of extracts from HeLa cells, using NF-kappaB p105/p50 (Phospho-Ser893) Antibody. The lane on the left is treated with the synthesized peptide.
Western blot of extracts from HeLa cells, using NF-kappaB p105/p50 (Phospho-Ser893) Antibody. The lane on the left is treated with the synthesized peptide.


Requested From: 
Date Requested: 6/22/2018

Get Social With Us! Follow us on Facebook Follow us on Google+ Follow us on LinkedIn PSL Alliance Member
Copyright © 2018 LifeSpan BioSciences, Inc. All Rights Reserved Privacy Policy



Catalog Number